Stockholders’ Equity (Tables)

3 Months Ended

Oct. 31, 2023

Stockholders’ Equity [Abstract]

Schedule of Share-based Compensation Expense

The amounts of share-based compensation expense recognized in the periods presented are as follows:

	Three months ended October 31,
	2023		2022
Stock options and performance stock units	$	646		180
Restricted stock units		429		186
	$	1,075		366

The following table sets forth the amount of expense related to share-based payment arrangements included in specific line items in the accompanying statements of operations:

	Three months ended October 31,
	2023		2022
Selling, general and administrative	$	1,069		360
Cost of revenues		6		6
	$	1,075		366

Schedule of Stock Option Activity

The following table summarizes stock option activity during the three month period ended October 31, 2023:

	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value (000s)
Outstanding at July 31, 2023		3,829,500		$	2.61				—
Granted		—			—
Exercised		—			—			$
Cancelled or expired		(508,916	)	$	1.58
Outstanding at end of period		3,320,584		$	2.64		2.5 years	$	—
Exercisable at end of period		2,313,784		$	2.83		1.9 years	$	—

Schedule of Summarizes Restricted Stock Unit (“RSU”) Activity

The following table summarizes RSU activity for the three months ended October 31, 2023:

	Number of  RSUs  outstanding			Weighted Average Fair Value per Unit at Date of Grant		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value (000s)
Outstanding at beginning of fiscal year		557,490		$	2.21		1.1 years		825
Granted		—		$	—				—
Vested		(173,333	)	$	3.39
Cancelled		(100,000	)	$	1.97
Outstanding at end of period		284,157		$	1.75		0.4 years	$	381
Expected to vest at end of period		284,157		$	1.75		0.4 years	$	381